Our program is designed for adults who are overweight or obese (BMI ≥25), especially those struggling with constant hunger or difficulty losing weight. All patients go through a doctor consultation to ensure the treatment is safe and appropriate.

Yes — GLP-1 medications are clinically approved and widely used globally. Our doctors monitor your progress and adjust dosage to minimize side effects.

Yes — your journey starts with a free doctor consultation. This ensures the treatment is tailored to your body, goals, and medical history.

Your program includes: GLP-1 medication such as Mounjaro, Wegovy, Ozempic and Rybelsus Doctor consultations Personalized diet guidance Ongoing support from our care team Everything is designed to make weight loss simple, structured, and sustainable.

GLP-1 medications are once-weekly injections using a simple pen device. They help reduce appetite, control cravings, and keep you fuller for longer.

No extreme dieting required. We provide practical, easy-to-follow nutrition guidance so you can lose weight without feeling restricted or overwhelmed.

Most patients lose 15-25% of their body weight over a few months, depending on consistency and dosage. Many also report reduced cravings and better control over eating habits.

Many patients notice: Reduced hunger within the first 1–2 weeks Visible weight loss within 4–6 weeks

Your medication is delivered across Qatar directly to your doorstep in temperature-controlled packaging to ensure safety and quality. Same-day or next-day delivery is available in most areas, and all medications are dispensed by a licensed pharmacy.

Prices vary depending on the medication, dosage, and length of treatment. Full pricing is provided after your first free consultation. Prices per injection range from 489 to 1,909 QAR depending on dosage.

Yes — we offer both oral tablets and injections, depending on what’s most suitable for you. Your doctor will recommend the best option based on your goals, medical history, and lifestyle.

Medications like Wegovy and Mounjaro mimic it to reduce hunger, curb cravings, and help you feel full longer—making weight loss easier and more sustainable.

GLP-1 treatments may not be suitable for individuals who are pregnant or breastfeeding, have certain thyroid conditions, pancreatic or severe gastrointestinal conditions, or Type 1 diabetes. Our doctors will carefully review your medical history to determine whether the treatment is safe and appropriate for you.

Consultations are provided by licensed doctors through Medihealth Solutions Doha, a licensed telehealth provider in Qatar.

You may pause or adjust your program based on your progress and doctor guidance. However, once medication has been delivered, it cannot be returned or exchanged.

SHORT FORM DISCLAIMER VALEO is a neutral technology platform that facilitates access between patients, licensed physicians, and licensed pharmacies in the State of Qatar. Healthcare providers and pharmacies participate independently pursuant to separate business-to-business service agreements administered through Medihealth Solutions Doha and other affiliated medical providers. Physicians are not employees, agents, or representatives of VALEO or any pharmacy, and no contractual or financial relationship exists between physicians and pharmacies through the platform. Physicians exercise independent professional judgment and do not sell, dispense, promote, or derive financial benefit from medications. Any service fees paid in connection with the platform relate solely to technology and administrative services and are not linked to prescriptions or pharmaceutical sales. VALEO does not endorse or advertise medical providers, pharmacies, or pharmaceutical products and operates in accordance with applicable laws and regulations of the State of Qatar, including Law No. (2) of 1983 regulating the practice of medicine and relevant Ministry of Public Health directives. ⸻ COMPREHENSIVE LEGAL DISCLAIMER VALEO is a technology-enabled marketplace that facilitates informational access and logistical connectivity between patients, licensed medical practitioners, and licensed pharmacies within the State of Qatar. VALEO does not provide medical care, pharmacy services, pharmaceutical dispensing, or clinical decision-making and shall not be construed as a healthcare provider, medical intermediary, or pharmacy operator. Participation by physicians and pharmacies on the platform occurs pursuant to separate business-to-business service agreements administered through Medihealth Solutions Doha. Such agreements are entered into independently with physicians and independently with pharmacies. Nothing contained within the platform, its operations, or its contractual arrangements shall be interpreted to create any partnership, joint venture, referral arrangement, agency relationship, or financial association between any physician and any pharmacy. Physicians available through the platform are independent licensed practitioners who exercise their professional judgment autonomously and in accordance with applicable laws, ethical duties, and professional standards in the State of Qatar. Physicians do not dispense, sell, supply, promote, or profit from medications provided by pharmacies and receive no commissions, incentives, rebates, or remuneration linked to pharmaceutical sales or dispensing activities. Pharmacies operate independently and exert no influence over medical advice, diagnoses, or prescriptions. The structure and operation of the platform are intended to comply with Law No. (2) of 1983 regulating the practice of medicine and all applicable Ministry of Public Health and Department of Healthcare Professions regulations, including prohibitions on physicians engaging in commercial activities related to pharmacies or pharmaceutical trade and restrictions on medical advertising and promotion. Any fees payable in connection with participation on the platform constitute service fees for technology, listing, administrative, and facilitation services only and are not contingent upon, calculated by reference to, or otherwise linked to the volume or value of prescriptions, medications dispensed, or patient referrals. VALEO does not endorse, recommend, rank, or advertise any physician, pharmacy, pharmaceutical product, or treatment modality. All information made available through the platform is provided for general informational and access purposes only. Patients retain full discretion and responsibility in selecting healthcare providers and pharmacies and in following medical advice and prescription instructions. Nothing in the platform shall be construed to establish a physician–patient relationship with VALEO, a contractual relationship between VALEO and any pharmacy in relation to patients, or any guarantee of medical outcomes, service availability, insurance coverage, or financial obligations. VALEO and Medihealth Solutions Doha affirm their commitment to compliance with all applicable laws, regulations, and regulatory directives in the State of Qatar.